Five Israeli teams fighting for a COVID-19 cure
Posted on
Israeli scientists and researchers are racing to find a cure for COVID-19, as global consensus is forming among medical professionals that vaccination is not going to eliminate corona.
When Israel launched its mass vaccination campaign, there were many who believed there would no longer be a need for medication, Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, told The Jerusalem Post.
“Now we know that this was an illusion,” he said. “Even in Israel, not everyone is taking the vaccine. There is quite a big population of youngsters under the age of 16 for whom it will be at least months until we have a vaccine.”
Could fibrates turn Covid effects into little more than common cold? - Technology & Health israelnationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israelnationalnews.com Daily Mail and Mail on Sunday newspapers.
Early clinical data demonstrates the efficacy of existing drug in treating COVID-19
In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem s Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.
The study was presented at the recent SPARK Conference on Generic Drug Repurposing for COVID-19 by Professor Yaakov Nahmias, Director of the Center for Bioengineering at Hebrew University. Nahmias applied a well-established existing drug to address the buildup of fats in human lung cells caused by the SARS-CoV-2 virus. Initial lab-based results and new data from 1,500 Israel-based Corona patients have been extremely promising and clinical studies are scheduled to begin this week at Barzilai Hospital in Ashkelon, Israel, joining other clinical centers across the United States, South America and Europe.
Credit: Daniel Hanoch
In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem s Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.
The study was presented at the recent SPARK Conference on Generic Drug Repurposing for COVID-19 by Professor Yaakov Nahmias, Director of the Center for Bioengineering at Hebrew University. Nahmias applied a well-established existing drug to address the buildup of fats in human lung cells caused by the SARS-CoV-2 virus. Initial lab-based results and new data from 1,500 Israel-based Corona patients have been extremely promising and clinical studies are scheduled to begin this week at Barzilai Hospital in Ashkelon, Israel, joining other clinical centers across the United States, South America and Europe.
Promising clinical data for fenofibrate s ability to prevent lung damage in COVID-19 patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.